黑色素瘤易感家族中胚系CDKN2A/CDK4状态与黑色素瘤起源皮肤模式变异
本研究采用病例-病例设计,比较美国黑色素瘤易感家族中CDKN2A突变携带者(141例,348个黑色素瘤)、CDK4突变携带者(15例,54个黑色素瘤)与非携带者(104例,157个黑色素瘤)的肿瘤部位差异。结果显示,相比躯干黑色素瘤,CDK4和CDKN2A携带者在其他所有部位发生黑色素瘤的比值比均显著升高。
要点
- CDK4携带者非躯干部位黑色素瘤风险显著高于非携带者。
- CDKN2A携带者非躯干部位黑色素瘤风险亦显著升高。
- 性别、年龄及首次/后续诊断分层分析结果相似。
核心结论
- CDK4和CDKN2A突变携带者相比非携带者,黑色素瘤更易发生于下肢、上肢及头颈等非躯干部位。
研究设计与样本
- 病例-病例研究,纳入美国黑色素瘤易感家族成员:CDKN2A携带者141例(348个黑色素瘤)、CDK4携带者15例(54个黑色素瘤)、非携带者104例(157个黑色素瘤)。
主要发现
- 相比躯干黑色素瘤,CDK4携带者下肢OR=14.5(95%CI 5.02-42.0,P<0.001),上肢OR=6.88(95%CI 2.37-19.9,P<0.001),头颈OR=18.6(95%CI 4.04-85.2,P<0.001)。
- 相比躯干黑色素瘤,CDKN2A携带者下肢OR=3.01(95%CI 1.56-5.82,P<0.05),上肢OR=1.91(95%CI 1.03-3.52,P<0.05),头颈OR=5.40(95%CI 2.10-13.9,P<0.001)。
- 按性别、年龄及首次与后续黑色素瘤诊断分层分析,结果相似。
临床怎么用
- 对CDK4/CDKN2A突变携带者进行皮肤检查时,应重点关注非躯干部位(下肢、上肢、头颈)的黑色素瘤筛查。
局限性
- 需进一步研究理解这些基因型相关肿瘤发生模式的生物学机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CDKN2A and CDK4 are well-established melanoma susceptibility genes, but their effect on tumor location and distribution is unknown. We used a case-case study design to assess for differences in tumor location between mutation carriers (CDKN2A = 141 patients, 348 melanomas; CDK4 = 15 patients, 54 melanomas) and noncarriers (104 patients, 157 melanomas) in US melanoma-prone families. Associations between groups were assessed with chi-square tests. Odds ratios (ORs) for tumor location were adjusted for diagnosis age, gender, and superficial spreading subtype. Models included random effects to account for within individual and family correlations. Compared with having a truncal melanoma, CDK4 (vs. noncarriers: lower extremities OR = 14.5, 95% confidence interval [CI] = 5.02-42.0, P < 0.001; upper extremities OR = 6.88, 95% CI = 2.37-19.9, P < 0.001; head and neck OR = 18.6, 95% CI = 4.04-85.2, P < 0.001) and CDKN2A (vs. noncarriers: lower extremities OR = 3.01, 95% CI = 1.56-5.82, P < 0.05; upper extremities OR = 1.91, 95% CI = 1.03-3.52, P < 0.05; head and neck OR = 5.40, 95% CI = 2.10-13.9, P < 0.001) carriers had higher odds of developing melanoma at all other sites. Similar findings were observed for analyses stratified by gender, age, and first versus subsequent melanoma diagnoses. Further studies are needed to understand the biology underlying these genotype-associated patterns of tumor development, which could provide new insights into melanoma treatment and prevention.
引用
- Sargen MR, Pfeiffer RM, Yang XR, et al. Variation in Cutaneous Patterns of Melanomagenesis According to Germline CDKN2A/CDK4 Status in Melanoma-Prone Families. J Invest Dermatol. 2019. PMID: 31326397. doi:10.1016/j.jid.2019.06.138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。